Clinical Trial Update: The FibreGum Study - Changing the Course of Obesity in Children [NA]

View source ↗

Summary

The FibreGum Study, a pediatric obesity trial sponsored by Insel Gruppe AG and University Hospital Bern, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adolescent Obesity
• Obesity

Drugs mentioned

• FibreGum

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Nutritional and Metabolic Diseases, Child Obesity | NA | Status: TERMINATED